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Transitory increase in creatinine 
levels after parathyroidectomy: 
evidence of another action of 
the parathyroid glands?
Alteração transitória da creatinina após paratireoidectomia: 
evidência de outra ação das glândulas paratireoides?
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Claudia B. Helou4, Sergio A. Toledo3, Anói C. Cordeiro1, Luiz E. Ianhez2
ABSTRACT 
Objective: Little information is available on glomerular function changes after surgical treatment 
of primary hyperparathyroidism. The acute effects of some head and neck operations on renal 
function were studied. Materials and methods: Retrospective analysis of changes in creatinine 
levels and estimated glomerular filtration rate (eGFR) after surgery. Preoperative values were 
compared with values available until 72 hours after the operation. Results: In tertiary hyper-
parathyroidism, mean preoperative and postoperative eGFR values were 57.7 mL/min and 40.8 
mL/min (p < 0.0001), respectively. A similar decrease was observed after parathyroidectomy for 
primary hyperparathyroidism, from 85.4 mL/min to 64.3 mL/min (p < 0.0001). After major head 
and neck procedures, there was a slight increase in eGFR (from 94.3 mL/min to 105.4 mL/min, 
p = 0.002). Conclusions: Parathyroidectomy may be followed by a transient decrease in eGFR 
that is not often observed in other head and neck operations. Arq Bras Endocrinol Metab. 2011;55(4):249-55
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RESUMO
Objetivo: Há pouca informação sobre alterações da função glomerular após o tratamento 
cirúrgico do hiperparatireoidismo primário. O efeito agudo sobre a função renal foi estuda-
do após algumas operações em cirurgia de cabeça e pescoço. Materiais e métodos: Análise 
retrospectiva dos níveis de creatinina e da taxa de filtração glomerular estimada (eGFR). Os 
valores pré-operatórios foram comparados aos valores disponíveis até 72 horas após a opera-
ção. Resultados: No hiperparatireoidismo terciário, os valores médios pré e pós-operatórios 
da eGFR foram 57,7 mL/min e 40,8 mL/min (p < 0,0001), respectivamente. O decréscimo após 
paratireoidectomia por hiperparatireoidismo primário foi de 85,4 mL/min para 64,3 mL/min (p 
< 0,0001). Após operações maiores de cabeça e pescoço, houve leve elevação da eGFR (de 94,3 
mL/min para 105,4 mL/min, p = 0,002). Conclusões: A paratireoidectomia pode ser seguida de 
uma redução transitória na eGFR que não é frequentemente observada após outras operações 
em cabeça e pescoço. Arq Bras Endocrinol Metab. 2011;55(4):249-55
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INTRODUCTION
In hyperparathyroidism (HPT), hypocalcemia is the most frequently voiced concern after different mo-
dalities of parathyroidectomy. In primary HPT, the 
postoperative course after resection of parathyroid ade-
noma is now usually uneventful in developed countries, 
and many patients are discharged on the day of the op-
eration or on the next day (1). 
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However, in renal transplant patients with persis-
tent HPT, acute and transient kidney injury has been 
described after parathyroidectomy (2). Chronic renal 
allograft damage was reported after subtotal (3) or total 
parathyroidectomy with autotransplantation (4). 
In one study, there was a consistent correlation be-
tween transient decrease in transplanted kidney func-
tion and decrease in parathyroid hormone (PTH), 
shortly after parathyroidectomy (5).
Because of this, we reviewed our own cases of HPT. 
If creatinine increase is associated with PTH reduction, 
renal transplant patients who underwent operations not 
related to the parathyroid glands would exhibit a diffe-
rent pattern. Indeed, while there was a mean increase 
of 39.5% in creatinine levels after parathyroidectomy, 
there was a mean decrease of 2.7% after other head and 
neck operations in renal transplant patients (6). 
If the increase in creatinine levels is related to de-
creases in PTH, a similar increase would be expected 
in patients with primary HPT undergoing parathyroi-
dectomy. The aim of the present study was to evaluate 
changes in creatinine levels and in estimated glomerular 
filtration rates (eGFR) after parathyroidectomy or some 
other head and neck operations, in order to validate our 
previous observations in a larger number of patients. 
MATERIALS AND METHODS
This retrospective study was approved by the research 
ethics committee of our institution. We analyzed acute 
creatinine changes in patients operated on for tertia-
ry HPT after renal transplantation (tHPT) or primary 
HPT (pHPT), from 1997 to 2007, at the Department 
of Head and Neck Surgery in the Faculdade de Medi-
cina at Universidade de Sao Paulo. Acute change was 
defined as occurring in up to 72 hours of the operation.
Results of patients with tHPT and pHPT were com-
pared with observations in random but non-consecutive 
patients submitted total thyroidectomy (TT), thyroid 
lobectomy (L), or other major head and neck proce-
dures (MAJOR HNS), as well as kidney transplant pa-
tients operated on for non-parathyroid head and neck 
tumours (NON PTX RENAL TX). MAJOR HNS in-
cluded malignant and benign diseases (most cases were 
squamous cell carcinoma of the upper aerodigestive 
tract, but some cases included parotid tumours, mela-
noma, skull base surgery, or angiofibroma). For pre-
operative evaluation, patients usually undergo serum 
creatinine test from days up to six months prior to the 
operation. On first day after surgery, MAJOR HNS pa-
tients stay at the intensive care unit, and serum creati-
nine is always included in routine laboratory work up. 
At our institution, creatinine is not always requested 
after thyroidectomy, but the test is carried out in some 
patients, in conjunction with calcium and/or PTH 
evaluation, as requested by endocrinologists in other 
studies. Thus, these results were available for our retro-
spective analysis.
After our initial observation of a possible acute 
change in renal function, analysis of postoperative cre-
atinine levels after parathyroidectomy or thyroidectomy 
became more frequent, but it is still not routine prac-
tice. Serum creatinine after thyroidectomy or parathy-
roidectomy is requested on the preference of the at-
tending surgeon or endocrinologist.
 The eGFR was calculated according to the Modifica-
tion of Diet in Renal Disease (MDRD), using creatinine, 
age, gender and race, in an internet-based open resource 
at the National Kidney Foundation, available at http://
www.kidney.org/professionals/kdoqi/gfr_calculator.cfm.
Percent creatinine variation (PCV) was calculated as 
follows: PCV=(Postoperative Creatinine - Preoperative 
Creatinine) x 100/(Preoperative Creatinine). A positi-
ve value reflects increased creatinine levels and possible 
decrease in renal function. Percent change of creatinine 
is a widely accepted tool to evaluate changes in renal 
function in clinical studies (7). While PCV has its li-
mitations, it prevents the inappropriate comparison of 
absolute changes in creatinine values between patients 
with very different basal creatinine levels, i.e., it is not 
appropriate to compare a 0.5 mg/dL increase in a pa-
tient with basal creatinine level of 0.9 mg/dL (55.6% 
increase) with that of a patient with preoperative creati-
nine level of 2.0 mg/dL (25% increase).
As a retrospective analysis, postoperative creatinine 
was not available for all patients on every postoperative 
day. In the present study, the highest value of serum 
creatinine was employed to calculate PCV only if the 
measurement was obtained up to the third postoperati-
ve day. Tests obtained later were not considered in this 
study, and these cases were excluded. When available, 
calcium, phosphorus and PTH levels were included. 
Statistical analysis included the Kolmogorov-Smir-
nov test to assess the normality of distribution. Paired 
Student’s t test was employed for normal distribution 
and Non-parametric Wilcoxon signed rank test was 
used for non-normal distribution. One-way ANOVA 
with Tukey’s test or Kruskal-Wallis test for multiple 
groups with Dunn’s Multiple Comparison test for pai-
red group comparison were also employed. Standard 
deviation is abbreviated as SD.
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RESULTS
Gender distribution was not comparable in all groups. 
The proportion of males was higher in patients sub-
mitted to major head and neck procedures, as show in 
table 1. Age distribution differed for MAJOR HNS and 
TT groups (p < 0.05, Tukey’s Multiple Comparison 
test). In all other situations, mean age was not signifi-
cantly different.
Mean of available values for total calcium before and 
after the operation, in patients undergoing total thyroi-
dectomy, were 9.1 mg/dL and 7.8 mg/dL, respecti-
vely. Preoperative and postoperative values were avai-
lable for 17 cases Preoperative mean was 9.0 mg/dL 
and postoperative mean was 7.8 mg/dL (p < 0.0001, 
paired t test). For lobectomy cases, paired values were 
available for 7 situations. Their preoperative mean was 
8.9 mg/dL and postoperative mean was 8.2 mg/dL 
(p = 0.0482, paired t test).
Mean of available values for total calcium, phospho-
rus and median of available PTH in patients with tHPT 
and pHPT are shown in table 2. 
In pHPT, there were 75 cases of parathyroid ade-
noma. Only one patient required a second operation 
to achieve success (1.33% of these cases). Creatinine 
values were available only for the first procedure (when 
HPT persisted): preoperative level was 0.9 mg/dL and 
postoperative level, 0.8 mg/dL. 
Of two patients with parathyroid carcinoma, the 
disease recurred in one of them, who was reoperated 
three years later. His creatinine values were available on 
both occasions. In 24 patients with Multiple Endocrine 
Neoplasia type 1 pHPT (MEN 1), two were reoperated 
approximately fours years after the first operation due 
to recurrent pHPT. Their creatinine levels were availa-
ble in both operations. Thus, in the present study, the-
re were 112 patients operated on for pHPT, but there 
were 115 cases for the comparison of creatinine values 
(112 patients plus three additional operations). Table 3 
shows the distribution of pHPT cases.
Mean and SD of preoperative creatinine values 
are depicted in table 4. Distribution of all groups was 
normal, except for pHPT distribution. Kruskal-Wallis 
test showed a significant difference in preoperative cre-
atinine values between groups (p < 0.0001). Dunn’s 
multiple comparison test showed that kidney trans-
plant patients had a significantly higher preoperati-
ve creatinine levels compared with the other groups; 
however, mean preoperative creatinine level of tHPT 
(1.40 mg/dL) was not statistically different from the 
mean of the NON PTX TX RENAL group (1.69 mg/dL) 
(p > 0.05).
In the MAJOR HNS group, distribution of pre- 
and postoperative creatinine levels were normal, and 
paired Student’s t test showed no difference betwe-
en preoperative and postoperative creatinine levels 
(p = 0.11). The same was true for the L group 
(p = 0.37), NON PTX RENAL TX patients (p = 0.46), 
and the TT group (p = 0.16).
In patients with pHPT, postoperative creatinine 
level was significantly higher than preoperative level 
(p < 0.0001). A similar result was observed in the tHPT 
group (p < 0.0001; Wilcoxon signed rank test). When 
all groups were compared by Kruskal-Wallis test, p va-
lue was < 0.0001.
Preoperative eGFR of patients undergoing ma-
jor head and neck surgery was not statistically diffe-
rent from preoperative eGFR of thyroid operations 
or pHPT, but it was significantly higher than tHPT 
(p < 0.001) and NONPTX RENAL TX patients (p < 
0.01) (Dunn’s Multiple Comparison test). Preopera-
tive eGFR of thyroidectomy patients was higher than 
that of pHPT (p < 0.05) and renal transplant cases. 
The eGFR of patients before lobectomy was only diffe-
rent from the eGFR of tHPT cases (p < 0.05). Table 5 
shows preoperative and postoperative eGFR values.
Table 1. Age and gender distribution
n Mean age (range) Male:female
MAJOR HNS 54 57.3 (16-82) 40:14
TT 24 43.4 (12-72) 8:16
L 9 52.7 (28-86) 1:8
NON PTX RENAL TX 7 50.4 (17-76) 3:4
t HPT 41 48.8 (23-68) 15:26
pHPT 115 53 (17-83) 32:83
Table 2. Values of calcium, phosphorus (in mg/dL) and PTH (pg/mL) before and after the operation
Calcium, 
preoperative
Calcium,
postoperative
Phosphorus, 
preoperative
Phosphorus,
postoperative
PTH,
preoperative
PTH, 
postoperative
tHPT 11.4 9.2 2.7 3.8 200 0
pHPT 11.7 9 2.6 3.2 157.5 6
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Table 4. Pre-and postoperative creatinine levels (mg/dL)
Mean 
preoperative 
creatinine (SD)
Range
Mean 
postoperative 
creatinine (SD)
Range
p*
MAJOR HNS 0.88 (0.18)
0.54 -1.27
0.84 (0.26)
0.44 - 1.55
0.07
TT 0.77 (0.22)
0.45 - 1.45
0.80 (0.27)
0.48 – 1.54
0.30
L 0.83 (0.37)
0.51 - 1.75
0.90 (0.37)
0.57 - 1.70
0.37
NON PTX RENAL TX 1.69 (0.92)
0.86 - 3.10
1.57 (0.74)
0.80 - 2.90
0.46
t HPT 1.40 (0.55)
0.75 -3.30
1.92 (0.83)
0.80-4.38
< 0.0001
pHPT 1.04 (0.59)
0.30 - 3.76
1.38 (0.89)
0.40 - 6.80
< 0.0001
* Determined by paired t test, except in pHPT (Wilcoxon signed rank test).
Table 5. Pre- and postoperative Estimated Glomerular Function Rate 
(eGFR) in mL/min x 1.73 sqm
Mean 
preoperative 
eGFR (SD)
Mean 
postoperative 
eGFR (SD)
p*
MAJOR HNS 94.3 (25.1) 105.4 (37.2) 0.0021
TT 107.4 (35.7) 104.7 (35.7) 0.54
L 93.3 (29.4) 86.3 (30.5) 0.32
NON PTX RENAL TX 50.7 (26.5) 52.7 (27.2) 0.62
t HPT 57.7 (20.3) 40.8 (15.5) < 0.0001
pHPT 85.4 (49.1) 64.3 (34.0) < 0.0001
* Determined by paired t test, except in pHPT (Wilcoxon signed rank test).
Table 6. Percent change of creatinine levels 
t HPT pHPT TT L MAJOR HNS
NON PTX 
RENAL TX
n 41 115 24 9 54 7
PCV* (%) mean +39.2 +33.1 +4.2 +11 -5.3 -2.7
PCV (%) median +30 +27 +1 -1 -8.3 -6.4
* PCV = (Postoperative Creatinine - Preoperative Creatinine) x 100/(Preoperative Creatinine). 
Table 3. Distribution of pHPT cases
pHPT Number of patients
Number of situations 
when creatinine was 
analyzed
Adenoma 75 75
MEN 1 HPT 24 26
Sporadic hyperplasia 8 8
Double adenoma 2 2
Carcinoma 2 3
MEN type 2A HPT 1 1
Total 112 115
Figure 1 is a graphical depiction of eGFR distribu-
tion in all groups, excluding cases with preoperative 
eGFR greater than 150 mL/min/1.73 sqm. Results 
were not affected by the exclusion of these individuals, 
and exclusion was done to improve data presentation. 
Values calculated for PCV of all groups are shown in 
table 6. Figure 2 shows that the distribution of PCV 
in the different groups was clearly different in patients 
undergoing parathyroid surgery.
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Figure 1. Pre- and postoperative estimated glomerular filtration rate (eGFR). 
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Figure 2. Individual distribution of PCV in all groups (the bar indicates the mean).
DISCUSSION
Renal changes in HPT are largely and frequently attri-
butable to acute and chronic excessive calcium in the 
circulation. Thus, resolution of hypercalcemia would 
theoretically be followed by kidney improvement, if ir-
reversible kidney damage has not occurred. 
More recently, however, a transient decrease in renal 
function after parathyroidectomy for tertiary HPT was 
correlated with a decrease in PTH levels (5). This led us 
to review cases of patients with primary HPT. Althou-
gh resection was performed in only one gland in most 
cases, a similar acute rise of creatinine was observed. 
Analysis of this effect on other head and neck proce-
dures showed that creatinine levels were more stable in 
patients without HPT, except those undergoing thyroi-
dectomy (6). Although this is a retrospective study with 
many limitations (e.g., time span between sampling, 
time of day when the blood was obtained, diet or in-
tervening medications), these results are in accordance 
with the 1958 observations of Edvall on renal function 
in primary HPT (8). 
Acute elevation of creatinine levels after parathyroi-
dectomy in pHPT was briefly discussed by Peacock 
(9), who apparently demonstrated that this increase 
was more marked in patients with higher preoperative 
creatinine levels. However, in another study, we obser-
ved that mean eGFR decrease occurred at similar ra-
tes, irrespective to preoperative renal function in pHPT 
(-21.8% in patients with severe to moderate kidney 
disease, -30.3% in mild kidney disease, and -21.8% in 
normal individuals) (10). 
In fact, present observations suggest that a more 
complex pattern can be observed even in patients with 
lower creatinine levels before the operation. Changes in 
creatinine levels may be very small, within normal limits 
and transient, but in other cases, a more marked in-
crease can be detected. It is remarkable that creatinine 
changes did not exhibit the same pattern in all patients 
after parathyroidectomy for pHPT. In some of them, it 
increased while in others it was unchanged, or apparen-
tly decreased (10,11). 
The retrospective nature of the present study may 
also interfere with these observations because preope-
rative creatinine was not measured just before the ope-
ration; in some cases, it was measured months prior to 
surgery. Another problem is the use of only a single 
postoperative value, which may obscure actual creati-
nine patterns. 
Unfortunately, very important data, such as diabetes 
and hypertension, could not be retrieved. During the 
period analyzed, there was no postoperative standard 
therapy for calcium reposition to avoid hypocalcemia 
both due to hungry bone syndrome and/or hypopar-
athyroidism. In relation to hypoparathyroid status, the 
possibility of hypoparathyroidism after total thyroidecto-
my could confound the comparison with pHPT. Indeed, 
the pattern observed in figure 2 shows that the percent 
increase of creatinine after thyroidectomy seems to be 
Renal function after parathyroidectomy
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halfway between pHPT and Major HNS. For academic 
purposes, a prospective study would clarify this issue. 
Calcium and calcitriol are usually prescribed in hy-
poparathyroid states. Excessive calcium replacement 
may have occurred in some cases, although mean post-
operative calcium was normal in the present study. 
Excessive calcium in the circulation seems to cause va-
soconstriction of the renal glomerular afferent arteri-
ole. Thus, abrupt drop in PTH, when compared with 
the slow decrease of excessive calcium in the circula-
tion (caused by natural slow decrease or calcium sup-
plementation), could explain the transient decrease in 
renal function before normalisation of calcemia. How-
ever, results of Lins do not favour this assumption; he 
observed that renal function does not improve signifi-
cantly after correction of calcemia following a parathy-
roidectomy, although a notable improvement in renal 
function was observed after correction of hypercalce-
mia in other causes, suggesting a different pattern of 
PTH-dependent hypercalcemia (12). It should be re-
membered that changes in intracellular calcium are not 
currently monitored. Intracellular calcium may play an 
important, but yet undefined role. The same might be 
true for calcium-sensing receptors in the kidney. 
An important point to be addressed is parathyroid 
secretion, which is abruptly changed by parathyroid-
ectomy, as observed in the present series (Table 2). Is 
PTH itself directly affecting renal function? Do direct 
physiological actions of PTH on renal function clearly 
explain present observations? In one study, postopera-
tive creatinine changes were only correlated to the de-
gree of PTH decrease after parathyroidectomy in renal 
transplant patients (5). 
In relation to circulatory or renal effects of active 
PTH fragments or parathyroid extract infusion, Massry 
and cols. noted that many contradictory results have 
been published (13). One possible clinical model to 
observe PTH action on renal function is its clinical use 
in osteoporosis treatment. In a randomised trial with 
subcutaneous injection of 1-34 PTH, a significant in-
crease in serum creatinine was observed after the fourth 
month of treatment (14). It is curious that in a study 
with 1-84 PTH injection, measured creatinine clear-
ance tended to increase in PTH-treated patients, but 
remained relatively stable in placebo patients (15). 
Considering these facts and the present observations, 
one may wonder if direct and indirect effects of differ-
ent PTH fragments on renal function deserve further 
basic research.
In the present series, postoperative creatinine 
changes could be, in part, related only to the use of 
drugs, such as nonsteroidal anti-inflammatory drugs 
(NSAIDs), during surgery, a rather common practice 
in anaesthesia (16). Indeed, Lee and cols. concluded 
that NSAIDs cause a clinically unimportant transient 
reduction in renal function in the early postoperative 
period (16). Another possibility would be that HPT 
patients are more sensitive to the nephrotoxic effects of 
a NSAID or other agents commonly employed in anes-
thesia. Could a recent parathyroidectomy aggravate the 
nephrotoxicity of some drugs and affect present results? 
In experimental studies, parathyroidectomy was dem-
onstrated to be associated with reduced nephrotoxicity 
of cisplatin (17) and gentamicin (18). The mechanism 
for this kind of protection was unclear. 
Transitory creatinine increase may be clinically un-
important, but its impact on long-term renal function 
is presently unknown. Until proven otherwise, how-
ever, the present observation may point out that any 
potential nephrotoxic drug should be avoided or used 
judiciously during or early after parathyroidectomy. 
Perhaps a parallel with contrast induced nephropathy 
may be of value. Are we able to identify patients at risk 
or define protective measures when planning the treat-
ment of patients with acute reduction of parathyroid 
function? (19). 
An increase in creatinine levels not reflecting an 
actual reduction in glomerular renal function may be 
questioned in the present series. The possible interfer-
ence on tubular secretion of creatinine should be taken 
into account (20). Thus, creatinine increase would not 
represent glomerular renal change, but only reduced 
tubular secretion of the marker. However, some pa-
tients presented oliguria after parathyroidectomy in 
the middle of the last century, as noted by Fuller Al-
bright (11). Another hint to a real renal dysfunction 
is the rare but alarming acute effect on chronic kidney 
injury that occurs in some patients immediately after 
parathyroidectomy (21,22). This problem may be un-
derreported in the literature, as physicians may consider 
that other causes of acute kidney injury may lead to 
acute or chronic renal disease after parathyroidectomy, 
in primary HPT patients with some degree of chronic 
kidney disease. 
Alternatively, one may suggest that “spontaneous” 
increase in creatinine occurs in hospitalised patients, 
based on a recent paper questioning the overestima-
tion of contrast induced nephropathy (23). It is pos-
Renal function after parathyroidectomy
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sible that creatinine increases spontaneously in different 
measurements; however, a careful reading of the study 
shows that the authors are not saying that at all: they 
only demonstrate that creatinine may change due to 
other factors affecting renal function, besides radiologi-
cal contrast. In their retrospective analysis, they could 
not rule out other potential risk factors to renal damage 
in the hospitalised population (23). The same criticism 
may be applied to the present study: as creatinine was 
not routinely requested, we may have included in the 
analysis patients presenting more risk factors. 
The present data showed there was a significant 
improvement in eGFR in patients undergoing major 
head and neck operations. This may be explained by 
overhydration during the operation and early postop-
erative period of these long operations. Low creatinine 
concentrations may be induced by overhydration (24).
In conclusion, a significant and transient change in 
creatinine levels may be observed right after parathy-
roidectomy. The mechanism underlying this phenom-
enon is apparently not yet understood. In our view, 
further basic research on the effects of different PTH 
fragments on renal function may be of scientific interest.
Disclosure: no potential conflict of interest relevant to this article 
was reported.
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